The Diabetes Care Devices Market is Segmented by Management Devices (Insulin Pumps, Insulin Syringes, and More), Monitoring Devices (Self-Monitoring Blood Glucose and Continuous Glucose Monitoring), by Patient Type (Type-1 Diabetes, Type-2 Diabetes and More), by End User (Hospitals & Clinics, Home-Care Settings and More) and Geography. The Market Forecasts are Provided in Terms of Value (USD).

The global diabetes care devices market is expected to reach USD 64.5 billion in 2024. The sales are expected to grow even higher and will be estimated at USD 117.7 billion in 2034 due to the rising diabetes population. The diabetes care devices market is anticipated to record a CAGR of 6.2% between 2024 and 2034.

Attributes	Description
Estimated Global Diabetes Care Devices Market Size (2024E)	USD 64.5 billion
Projected Global Diabetes Care Devices Market Value (2034F)	USD 117.7 billion
Value-based CAGR (2024 to 2034)	6.2%

Semi-annual Industry Update

Particular	Value CAGR
H1	5.7% (2023 to 2033)
H2	5.2% (2023 to 2033)
H1	4.5% (2024 to 2034)
H2	4.2% (2024 to 2034)

Country-wise Insights

Countries	CAGR 2024 to 2034
India	8.8%
China	8.4%
South Korea	8.1%
Australia	6.7%
France	4.3%
United States	3.4%

Category-wise Insights

Segment	Glucose Monitoring Devices (Product Type)
Value Share (2024)	58.3%

Segment	Diabetes Type II (Indication)
Value Share (2024)	19.7%

The diabetes care device market size is projected to grow from USD 39.82 billion in 2025 to USD 99.81 billion by 2035, representing a CAGR of 9.62% during the forecast period till 2035

Planned monitoring requirements combined with insulin requirements for diabetic pets among dogs and cats create a market need for specialized care devices. Pixel GPS medicine forecasts the market to achieve USD 2,594 million in 2025 but predicts an increase to USD 4,645.5 million by 2035 at a compound annual growth rate (CAGR) of 6%.

Metric	Value
Industry Size (2025E)	USD 2,594 million
Industry Value (2035F)	USD 4,645.5 million
CAGR (2025 to 2035)	6%

Country-Wise Outlook

Country	CAGR (2025 to 2035)
USA	6.4%

Country	CAGR (2025 to 2035)
UK	5.8%

Region	CAGR (2025 to 2035)
European Union	6.0%

Country	CAGR (2025 to 2035)
Japan	5.6%

Country	CAGR (2025 to 2035)
South Korea	6.2%

Segmentation Outlook - Pet Diabetes Care Devices Market

Device Type	Market Share (2025)
Glucose Monitoring Devices	57.9%

End-User Segment	Market Share (2025)
Veterinary Clinics	46.4%

Competitive Outlook

Company Name	Estimated Market Share (%)
Zoetis Inc.	20-24%
Trividia Health, Inc. (PetTest)	15-19%
Merck Animal Health	12-16%
UltiMed, Inc.	8-12%
i-SENS, Inc.	5-9%
Other Companies (combined)	30-40%

The Japan Diabetes Care Devices Market report segments the industry into Management Devices (Insulin Pump, Insulin Pens, Insulin Syringes, Jet Injectors) and Monitoring Devices (Self-monitoring Blood Glucose, Continuous Glucose Monitoring). Get five years of historical data alongside five-year market forecasts.

The Report Covers Germany Diabetes Management Companies and the Market is Segmented Into Monitoring Devices (Self-Monitoring Blood Glucose and Continuous Glucose Monitoring) and Management Devices (Insulin Pumps, Insulin Disposable Pens, Insulin Syringes, Cartridges in Reusable Pens, and Jet Injectors), End User (Homecare and Hospital and Clinics). The Market Provides the Value (in USD) for the Above Segments.

Diabetes Care Devices market witnessed USD 21,825.4 million in 2022 and is estimated to touch USD 33,750.0 million by 2030, growing at a CAGR of 5.6% till 2030

The size of the Diabetes Care Devices Market in Mexico market was valued at USD 503 Million in 2023 and is projected to reach USD 755.33 Million by 2032, with an expected CAGR of 5.98% during the forecast period.Diabetes care devices are very important tools to aid diabetic patients to manage their disorder. They help monitor blood sugar levels, administer insulin and log food intake. Blood glucose meters measure the blood sugar; patients can then take corrective action with their dosages of insulin or change their dieting habits. Insulin pumps administer insulin continuously or at programmed intervals, thereby providing greater accuracy for blood sugar control. Continuous glucose monitors monitor blood sugar levels throughout the day, though they measure in real time, they reduce the number of finger pricks needed for carbohydrate quantities. More amazingly, people have monitoring devices that record carbohydrate intake and calculate how much insulin is needed. All this has greatly improved the quality of life for the people affected with diabetes as it is almost impossible for better disease management, prevention of complications, and improved overall well-being. Recent developments include: October 2022: Becton, Dickinson, and Company and Biocorp signed an agreement to use connected technology to track adherence to self-administered drug therapies, like biologics. To support biopharmaceutical companies in their efforts to improve the adherence and outcomes of injectable drugs, the two companies will integrate Biocorp's Injay technology. It is a solution designed to capture and transmit injection events using Near Field Communication technology to the BD UltraSafe Plus Passive Needle Guard used with pre-fillable syringes., June 2022: Abbott announced that it's developing a new bio-wearable that will continuously monitor glucose and ketone levels in one sensor. The glucose-ketone sensor will be the same size as Abbott's FreeStyle Libre 3 sensor, the world's smallest and thinnest continuous glucose monitoring sensor. It will connect to Abbott's digital ecosystem, including personal and caregiver mobile apps and cloud-based data management software for remote monitoring by healthcare professionals.. Key drivers for this market are: Rising Prevalence of Cancer Worldwide, Technological Advancements in Diagnostic Testing; Increasing Demand for Point-of-care Treatment. Potential restraints include: High Cost of Molecular Diagnostic Tests, Lack of Skilled Workforce and Stringent Regulatory Framework. Notable trends are: Continuous glucose monitoring segment is expected to witness highest growth rate over the forecast period.

The Latin America Diabetes Care Devices Market report segments the industry into Monitoring Devices (Self-monitoring Blood Glucose Device, Continuous Glucose Monitoring Device), Management Devices (Insulin Pump, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, Jet Injectors), and Geography (Brazil, Mexico, Rest of Latin America). Get five years of historical data alongside five-year market forecasts.

Diabetes Care Devices Market Outlook

According to our latest research, the global Diabetes Care Devices market size reached USD 32.7 billion in 2024, reflecting robust demand across both developed and emerging economies. The market is expected to expand at a steady CAGR of 7.1% from 2025 to 2033, with the overall market projected to reach USD 60.7 billion by 2033. The growth of this market is primarily driven by the rising global prevalence of diabetes, technological advancements in glucose monitoring and insulin delivery, and increasing awareness regarding diabetes management and patient self-care.

The most significant growth factor for the diabetes care devices market is the alarming rise in diabetes incidence worldwide. A sedentary lifestyle, increasing obesity rates, and aging populations are contributing to a surge in both Type 1 and Type 2 diabetes cases. As a result, the demand for advanced blood glucose monitoring devices, continuous glucose monitoring systems, and innovative insulin delivery solutions is escalating. Furthermore, governments and healthcare organizations are launching various awareness campaigns and screening programs, which are boosting early diagnosis and, consequently, the adoption of diabetes care devices. The integration of digital health technologies and smartphone applications with diabetes care devices is also enhancing patient engagement and adherence, further fueling market growth.

Technological advancements play a pivotal role in shaping the diabetes care devices market landscape. Continuous innovations in glucose monitoring, such as the advent of minimally invasive and non-invasive monitoring systems, have significantly improved patient comfort and compliance. The introduction of smart insulin pens, closed-loop insulin delivery systems, and wearable continuous glucose monitors has revolutionized diabetes management, enabling real-time monitoring and precise insulin dosing. These advancements not only enhance patient outcomes but also reduce the burden of complications associated with poorly managed diabetes. Moreover, the integration of artificial intelligence and data analytics in diabetes care devices is empowering patients and healthcare professionals with actionable insights, fostering personalized treatment approaches.

The expansion of home-based diabetes care and the growing emphasis on patient-centric healthcare are also major contributors to market growth. With the increasing preference for self-monitoring and at-home care, there is a rising demand for user-friendly and portable diabetes care devices. This trend is further supported by the proliferation of online pharmacies and e-commerce platforms, making these devices more accessible to a broader patient population. Additionally, favorable reimbursement policies and the growing availability of diabetes care devices in retail and hospital pharmacies are facilitating market penetration, especially in emerging economies. As the focus on preventive healthcare intensifies, the adoption of diabetes care devices is expected to witness sustained momentum throughout the forecast period.

Regionally, North America dominates the diabetes care devices market, accounting for the largest share in 2024, followed by Europe and the Asia Pacific. The high prevalence of diabetes, advanced healthcare infrastructure, and strong presence of leading market players contribute to North America's market leadership. Meanwhile, the Asia Pacific region is poised for the fastest growth, driven by a rapidly increasing diabetic population, improving healthcare access, and rising awareness about diabetes management. Latin America and the Middle East & Africa are also witnessing steady growth, albeit from a smaller base, as healthcare investments and diabetes screening programs gain momentum in these regions.

Product Type Analysis

The diabetes care devices market is segmented by product type into blood glucose monitoring devices, insulin delivery devices, continuous glucose monitoring (CGM) systems, lancets, a

The global diabetes care devices market size was valued at USD 34.19 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 62.65 Billion by 2033, exhibiting a CAGR of 6.61% from 2025-2033. North America currently dominates the market, holding a market share of over 38.6% in 2024. The rising incidences of diabetes, rapid technological advancements, imposition of favorable government initiatives, increasing disposable incomes, integration of big data and analytics, and escalating geriatric population are some of the major factors propelling the market.

Report Attribute	Key Statistics
Base Year	2024
Forecast Years	2025-2033
Historical Years	2019-2024
Market Size in 2024	USD 34.19 Billion
Market Forecast in 2033	USD 62.65 Billion
Market Growth Rate (2025-2033)	6.61%

IMARC Group provides an analysis of the key trends in each segment of the global diabetes care devices market report, along with forecasts at the global, regional and country levels from 2025-2033. Our report has categorized the market based on type, distribution channel and end user.

The size of the South Korea Diabetes Care Devices Market market was valued at USD 457.06 Million in 2023 and is projected to reach USD 562.13 Million by 2032, with an expected CAGR of 3.00% during the forecast period. Currently, South Korea diabetes care devices market is in growth phase due to increasing diabetes cases along with increased awareness for proper management of diseases. Diabetes care devices are those instruments and apparatus that have been used for the monitoring of blood glucose level and it comprises of glucose meter, insulin delivery systems, continuous glucose monitoring systems and test strips. There are technological factors that currently form the market including the incorporation of health digital platforms and also enhancement of accuracy in the monitoring devices. In addition, factors such as a rising incidence of chronic diseases, a surge in the healthcare spending, and a higher level of adoption of government policies to curb diabetes and other diseases and a growing population of geriatrics add to the growth of the market. New trends include the use of wearables and integration of the device with real-time mobile applications feed. Recent developments include: January, 2023: Adela (Online Selling website for Abbott Free Style Libre in Korea) announced that the freestyle libre selling price is expected to be raised by 10% in Korea, due to continuous raise in raw materials and inflation., May 2022: EOFlow a provider of wearable drug delivery solutions announced the official launch of the iOS Version of 'Narsha,' a smartphone application for wearable insulin pumps in Korea.. Key drivers for this market are: Rising Prevalence of Cancer Worldwide, Technological Advancements in Diagnostic Testing; Increasing Demand for Point-of-care Treatment. Potential restraints include: High Cost of Molecular Diagnostic Tests, Lack of Skilled Workforce and Stringent Regulatory Framework. Notable trends are: Self-Monitoring Blood Glucose Devices occupy the highest market share in the monitoring devices segment in South Korea Diabetes Care Devices Market in the current year.

Snapshot img

Diabetes Management Devices Market Size 2024-2028

The diabetes management devices market size is forecast to increase by USD 13.98 bn at a CAGR of 7.68% between 2023 and 2028.

The market is witnessing significant growth due to the rising global burden of diabetes and the increasing focus on advanced technologies such as artificial pancreas systems. These systems utilize insulin pumps and continuous glucose monitoring sensors to automatically adjust insulin delivery based on real-time glucose levels. Additionally, the integration of artificial intelligence and data analytics in diabetes management devices is revolutionizing the industry, enabling remote patient monitoring and personalized treatment plans. Other trends include the development of insulin pens with advanced features and the adoption of spectroscopy technology for non-invasive blood glucose monitoring. However, the prohibitive cost of diabetes care devices remains a major challenge for market growth.Overall, the market is expected to experience robust growth In the coming years, driven by technological advancements and the increasing prevalence of diabetes.

What will be the Size of the Diabetes Management Devices Market during the Forecast Period?

Request Free SampleThe market encompasses a range of technologies designed to assist individuals in managing their diabetes, including insulin delivery devices, mobile health applications, and disease management tools. With the global diabetic population projected to reach over 592 million by 2035, driven by factors such as obesity rates, smoking, and high cholesterol levels, the market for diabetes care devices is experiencing significant growth. Hospitals and specialty clinics are increasingly adopting minimally invasive devices, such as diabetes lancet devices and diabetes tracker devices, to improve patient care and outcomes. Type 1 diabetes, an autoimmune disease characterized by insulin deficiency, and Type 2 diabetes, often associated with insulin resistance, both require ongoing management to prevent complications, including kidney failure, gangrene, and lower limb amputation.Insulin delivery devices, including insulin pens and blood glucose level monitoring systems, are essential tools in managing both types of diabetes. The market for diabetes management devices is expected to continue expanding as technology advances and the global population ages.

How is this Diabetes Management Devices Industry segmented and which is the largest segment?

The diabetes management devices industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments. ProductBlood glucose monitoring devicesInsulin delivery systemsDistribution ChannelOfflineOnlineGeographyNorth AmericaUSEuropeGermanyUKFranceAsiaChinaRest of World (ROW)

By Product Insights

The blood glucose monitoring devices segment is estimated to witness significant growth during the forecast period. Diabetes management devices play a crucial role in monitoring and managing blood glucose levels for individuals with diabetes. These devices include a range of products such as insulin delivery systems, continuous monitoring systems, and glucose monitoring devices. Insulin delivery devices, including insulin pumps and pens, facilitate precise insulin administration. Continuous monitoring systems, such as continuous glucose monitoring systems (CGMs) and Mobi insulin pumps, provide real-time glucose level data through wireless transmission and dedicated apps. Glucowear, a continuous glucose monitoring system, offers non-invasive transdermal sensors and spectroscopy technology. Hospital pharmacies, retail pharmacies, and online pharmacies stock these diabetes care devices. The increasing prevalence of diabetes among the obese, elderly population, and those with conditions like high cholesterol levels, smoking, and inactive lifestyles necessitates effective diabetes management.Disease management is essential to prevent complications like kidney failure, gangrene, lower limb amputation, heart attack, blindness, and stroke. Diabetes tracker devices, such as diabetes monitoring software and artificial pancreas systems, help healthcare providers analyze glucose patterns and create treatment plans. User-friendly interfaces, visual representations, and medication adherence features enhance the efficacy of treatment. In summary, diabetes management devices, including insulin delivery devices, continuous monitoring systems, and glucose monitoring devices, are essential tools for managing diabetes and preventing complications. These devices offer precision, flexibility, and smart features, making diabetes care more accessible and convenient for individuals with diabetes. Hospital segment, diagnostic centers, diabetes clinics, and healthcare professionals uti

GCC Diabetes Care Devices Market Market size, market analysis, Market Revenue, trends, Regional Outlook, competition and growth opportunities till 2026

Global diabetes care devices market worth at $32.92 Billion in 2024, is expected to surpass $75.11 Billion by 2034, with a CAGR of 8.6% from 2025 to 2034.

Indonesia Diabetes Care Devices Market is Segmented Into Management Devices (Insulin Pumps, Insulin Syringes, and More), Monitoring Devices (Self-Monitoring Blood Glucose and Continuous Glucose Monitoring), by Patient Type (Type-1 Diabetes, Type-2 Diabetes and More), by End User (Hospitals & Clinics, Home-Care Settings and More). The Market Forecasts are Provided in Terms of Value (USD).

South Korea Diabetes Care Devices Market size, market analysis, Market Revenue, trends, Regional Outlook, competition and growth opportunities till 2027

The size of the Canada Diabetes Care Devices market was valued at USD XXX Million in 2023 and is projected to reach USD XXX Million by 2032, with an expected CAGR of 4.98% during the forecast period.This medical device enables diabetic patients to deal with the condition appropriately. Typically, it encompasses blood glucose meters, continuous glucose monitoring systems, insulin pumps, and pen injectors. This device determines blood sugar via blood glucose meters, maintains blood glucose measurements at all times, day and night, with CGM systems, releases the appropriate amount of insulin by means of insulin pumps, and injects insulin using the pen injector.Primary factors driving the Canadian market for diabetes care devices are the rising incidence of diabetes in the country, fast aging population, and increasing healthcare expenditure. Increasing awareness towards early diagnosis and frequent blood sugar monitoring has enhanced demand for diabetes care devices. Moreover, the growth of the market is highly facilitated by technological improvements in diabetes care devices, such as more precise and user-friendly CGM systems and insulin pumps.Government initiatives for better diabetes care coupled with encouraging reimbursement policy for diabetes devices increase the Canadian market. The increasing trend of personalized medicine and telemedicine by the healthcare industry is expected to make innovative diabetes care devices continue their high demand in Canada. Recent developments include: July 2022: NuGen Medical Devices Inc. announced that its needle-free injection system and accessories, also known as InsuJet, were approved by Health Canada specifically for needle-free insulin delivery., March 2022: The Ontario government announced that it would provide coverage for the Dexcom G6 CGM System through Ontario's Assistive Devices Program (ADP) for people in the province with type 1 diabetes who are over 2 years of age and meet coverage criteria. The Non-Insured health benefits program also covers first nations and Inuit children. With expanded public coverage for CGM, more people can access this standard care technology, helping them to manage life-long chronic illnesses more effectively.. Key drivers for this market are: , The Rise in Global Prevalence of Cases of Obesity due to Modern Sedentary Lifestyles; Rise in Awareness and Disposable Income in Developed Economies. Potential restraints include: , Highly Cost of Branded Products in Emerging Countries; Severe Adverse Associated with Medication Including Seizures, Suicidal Attempts and Even Death; Adoption of Traditional Yoga and Herbal Products. Notable trends are: Rising Diabetes Prevalence in Canada.

The US diabetes devices market, a significant segment of the global market, is experiencing robust growth, driven by the rising prevalence of diabetes and an aging population. The market, valued at approximately $25.16 billion in 2025, is projected to expand at a Compound Annual Growth Rate (CAGR) of 6.27% from 2025 to 2033. This growth is fueled by several key factors: increasing adoption of continuous glucose monitoring (CGM) systems offering improved diabetes management, technological advancements leading to smaller, more user-friendly devices, and growing awareness of the benefits of proactive diabetes care. The market is segmented into monitoring and management devices. Within monitoring, self-monitoring blood glucose (SMBG) devices, including glucometers, test strips, and lancets, remain a substantial portion, although CGM is experiencing faster growth due to its real-time data capabilities and improved patient outcomes. The management device segment is dominated by insulin delivery systems like insulin pumps, syringes, pens, and jet injectors, with insulin pumps showing particularly strong growth prospects due to their convenience and efficacy in managing insulin delivery. Competitive intensity is high, with major players like Abbott, Medtronic, Dexcom, and Novo Nordisk vying for market share through continuous innovation and strategic partnerships. The North American region, particularly the US, holds a significant market share owing to high diabetes prevalence, advanced healthcare infrastructure, and strong regulatory support for innovative medical technologies. The market's growth trajectory is expected to remain positive through 2033, although certain restraints could influence the pace. These include high costs associated with some devices, particularly CGMs and insulin pumps, creating access barriers for some patients. However, increasing insurance coverage and the development of more affordable alternatives are mitigating these challenges. Furthermore, technological advancements, such as the integration of artificial intelligence and machine learning in diabetes management, are expected to further enhance the market's potential. Companies are focusing on developing integrated systems that combine CGM with insulin delivery, providing a more holistic approach to diabetes management. This trend will likely drive further growth and consolidation within the market. Future success will depend on companies' ability to innovate, offer competitive pricing strategies, and address the evolving needs of patients. Recent developments include: August 2023: The US Food and Drug Administration (FDA) has granted clearance for Roche's Accu-Chek Solo micropump system, a tubing-free "patch" pump for people with diabetes who use insulin., March 2022: Dexcom released G7 first in the U.K. and was expected to expand the launch across Europe throughout 2022. Meanwhile, the CGM system currently is under review by the Food and Drug Administration for an eventual U.S. release.. Key drivers for this market are: Increasing Number of Preterm and Low-weight Births, Advanced Technology in Fetal and Prenatal Monitoring. Potential restraints include: Stringent Regulatory Procedures. Notable trends are: Growing Diabetes and Obesity Population in the United States.

The size of the Saudi Arabia Diabetes Care Devices Market market was valued at USD 665.10 Million in 2023 and is projected to reach USD 894.85 Million by 2032, with an expected CAGR of 4.33% during the forecast period. The Saudi Arabia Diabetes Care Devices Market is therefore on an upward trajectory in terms of growth due to factors such as increased prevalence of diabetes, growing population of senior citizens as well as rising cases of obesity. The devices include blood glucose meter, insulin pen, continuous glucose monitors abbreviated as CGM, test strips that help in diabetes. Education programs supported by the government, increased funding of health care facilities, and other related awareness campaigns have created awareness towards preventing and controlling diabetes. Recent innovations are seen in mobile app compatible diabetes devices that form the key trends in the diabetes management market which include wearable monitoring systems. So, the move toward patient self-care and the development of peripheral diagnostics enhance the need for diabetes care devices in Saudi Arabia. Recent developments include: July 2022: Under Vision 2030, the Saudi Arabian government plans to invest over USD 65 billion to develop the country's healthcare infrastructure. In addition, it aimed to increase the private sector's contribution from 40 percent to 65 percent by 2030, targeting the privatization of 290 hospitals and 2,300 primary health centers., May 2022: Tamer, the Middle East's healthcare distribution company, has agreed on a 5-year deal to bring Huma's technology platform to power 'hospitals at home' with remote patient monitoring to the 34 million people living in the Kingdom of Saudi Arabia. The new health program was to begin with support for patients with diabetes and cardiovascular disease.. Key drivers for this market are: Rising Prevalence of Cancer Worldwide, Technological Advancements in Diagnostic Testing; Increasing Demand for Point-of-care Treatment. Potential restraints include: High Cost of Molecular Diagnostic Tests, Lack of Skilled Workforce and Stringent Regulatory Framework. Notable trends are: Monitoring Devices Segment Expected to Register Significant Growth.